Mosquito-Borne Virus Leads to Years of Joint Pain

Select Language:

A team of scientists has uncovered a crucial clue explaining why some individuals endure persistent joint pain following infection with the mosquito-borne virus known as chikungunya.

Chikungunya virus, or CHIKV, is transmitted through mosquito bites and impacts over 110 countries worldwide. The majority of infected individuals experience flu-like symptoms, including fever, fatigue, rash, and joint discomfort, which often resolve within a few weeks.

However, for certain people, the joint pain persists for months or even years, evolving into a chronic issue that interferes with daily activities. Until now, the reasons behind this prolonged pain remained unclear.

Researchers at the La Jolla Institute for Immunology in the United States aimed to investigate this phenomenon. Their study, published in the journal Cell Reports Medicine, focused on how the body’s immune system responds after chikungunya infection.

The immune system functions to defend us from infections by utilizing various cell types to identify and eliminate viruses and bacteria. Among these, T cells are especially important—they help the immune system remember previous infections and respond rapidly if the pathogen reappears.

There are different T cell subsets, including CD4+ and CD8+ T cells. CD8+ T cells typically target and destroy infected cells directly, while CD4+ T cells support the immune response by guiding other immune cells.

In this research, scientists analyzed blood samples from individuals in Colombia who had previously fought off chikungunya. They examined how their T cells reacted to small viral fragments.

What they discovered was unexpected. The CD4+ T cells showed a remarkably strong and enduring response. Even six years after infection, 87% of patients still had these virus-specific CD4+ T cells circulating in their blood. In contrast, only 13% had comparable levels of CD8+ T cells related to the virus.

This pattern is uncommon for typical viral infections, where CD8+ T cells usually dominate the immune response. Instead, the pattern resembles what is observed in autoimmune diseases, such as rheumatoid arthritis.

Autoimmune conditions occur when the immune system attacks the body’s own tissues, leading to chronic inflammation and joint deterioration. The scientists suggest a similar process might be occurring in long-term chikungunya cases. The persistent activity of CD4+ T cells could induce ongoing inflammation in the joints, even after the virus has been cleared.

Additionally, the study noted that these CD4+ T cells often produced a specific inflammatory molecule called TNF-alpha. While normally vital for fighting infections, excessive or prolonged production of TNF-alpha can cause tissue damage.

In individuals suffering from chronic joint pain, these T cells predominantly produced only TNF-alpha, resulting in a “monofunctional” response—commonly linked to sustained inflammation.

This insight could explain why pain continues long after the infection has gone. It also hints at potential treatments: medications that block TNF-alpha, already used for autoimmune diseases like rheumatoid arthritis, might be beneficial for those experiencing lengthy joint issues post-chikungunya.

Researchers are now examining why some groups are more susceptible than others. Preliminary data suggest women in their 40s may be more prone to developing chronic symptoms. Scientists are investigating whether their immune systems are more inclined to mistakenly attack their own tissues.

This research forms part of broader efforts to understand how viral infections can lead to long-term health problems. Similar patterns have been identified in illnesses linked with other viruses, including dengue and COVID-19.

Experts increasingly recognize that infections can have lingering effects, with immune responses that persist beyond the initial illness, sometimes causing ongoing health issues.

While further studies are needed, this research represents a significant advancement in understanding long-term chikungunya symptoms. It offers potential avenues for treatment and improves our grasp of how the immune system may inadvertently contribute to disease.

Published in Cell Reports Medicine, this work underscores the complex role of the immune system in both fighting infections and sometimes driving chronic disease.